There may be a number of sources of this oxidative stress, including mitochondrial superoxide production, ischemia-reperfusion mechanisms and auto-oxidation of catecholamines
If you see no improvement by week 6 to 8, the peptide may not be well-suited to your particular condition
If you're a pharmaceutical company and you see that there's 15 to 20 other peptides which are really working and really working, because again, we've just seen the clinical response over and over and over, it's not a large leap to think, "Hey, if we're a pharmaceutical company, what if we turn that peptide, which was available to the commoner, for lack of a better term, into a drug?" Andrew: Oh, like Vyleesi
That familiar morning stiffness turned into persistent tenderness that forced me to cut training volume by half
Foundayo (Orforglipron) is sensitive to light